Brind.

Headwaters Capital Management highlighted Bio-Techne in its investor letter.

1 report, 1 independent Updated Jul 15

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Bio-Techne

Keep exploring

The entities involved

Bio-Techne
company
- Bio-Techne has entered a strategic partnership with Spear Bio to distribute its immunoassays, advancing therapeutic development.Sun 13:32
- Trump pledged to unleash American oil and gas, involving MBX Biosciences, Inc.Sun 05:01

Related events

Bio-Techne is facing scrutiny regarding its market performance and the growth of Protein Sciences, questioned by a UBS analyst.Jun 7

Coverage

Newest first; wire copies grouped

Jul 15Insider MonkeyHere’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH) Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A cop